KI-DX-014


Catalog Number Pack Size List Price* Quantity
HY-175238-5MG 5 mg 834,00 Add
HY-175238-1ML 10mM/1mL 915,00 Add
HY-175238-10MG 10 mg 1'324,00 Add
HY-175238-25MG 25 mg 2'629,00 Add
HY-175238-50MG 50 mg 4'192,00 Add
HY-175238-100MG 100 mg 6'697,00 Add

* CHF, excl. 8.1% VAT and shipping costs


Product Description

Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.

KI-DX-014 is a DDX21 inhibitor with an IC50 of 3.31 μM. KI-DX-014 significantly inhibits the DDX21-RNA interaction and modulates ATPase activity and biomolecular condensate formation. KI-DX-014 reduces the DDX21-dependent release of P-TEFb from the 7SK snRNP complex, inhibits P-TEFb-dependent phosphorylation of the RNA polymerase II CTD, and induces developmental defects in zebrafish embryos. KI-DX-014 can be used for cancers and neurodegenerative disorders research[1].

Category Biochemicals
Supplier MedChem Express
Regulatory Status RUO
Research Field Cancer, Neurological Disease
Grade Clinical information: No Development Reported
Molecular Formula C17H22N4O3
Molecular Weight 330.38
CAS-Number 1309288-83-2
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Shipping Details Room temperature
Material Safety Data Sheet Download PDF